mRNA-4157 / V940 + KEYTRUDA

Personalized Neoantigen mRNA Cancer Vaccine Simulator

Cohort:
1. Patient Neoantigen Profile & mRNA Cassette
MEL-4157-08
Tumor Mut Burden
18.4
mut/Mb (High)
HLA Alleles
A*02:01 / B*07:02
MHC-I Class
Cassette Size
2856
nucleotides (nt)
Mean IC50 Affinity
42.5
nM (High Affinity)
Synthetic Epitopes Selected: 34/34 (Click chips to toggle)
2. Live Cellular Immune Kinetics & Survival Benchmarking
MRD Negative
Microenvironment: DC Cross-Presentation & CD8+ T-Cell Cytotoxicity CD8+ Expansion: 46.2x
Kaplan-Meier Recurrence-Free Survival (3-Year Adjuvant Trajectory)
mRNA+Pembro
Pembro Alone
Hazard Ratio (HR): 0.56 (95% CI 0.31-0.98) Log-Rank P-Value: p = 0.0082
36-Mo Recurrence-Free Survival (RFS): 74.8% (vs 55.6% Control) Minimal Residual Disease Negative
Super generates helpful tools and automates fact-checking across the internet proactively. If you enjoyed this tool, build your own with Super and share it with a friend.